An updated patent review of metallo-ß-lactamase inhibitors (2020-2023).

Denakpo, Elsa; Naas, Thierry; Iorga, Bogdan I

Denakpo, Elsa; Naas, Thierry; Iorga, Bogdan I.

Affiliation

Denakpo E; Université Paris-Saclay, CNRS, Institut de Chimie des Substances Naturelles, Gif-sur-Yvette, France.
Naas T; Team ReSIST, INSERM U1184, School of Medicine Université Paris-Saclay, LabEx LERMIT, Le Kremlin-Bicêtre, France.
Iorga BI; Bacteriology-Hygiene unit, Assistance Publique/Hopitaux de Paris, Bicêtre Hospital, Le Kremlin-Bicêtre, France.

Expert Opin Ther Pat ; 33(7-8): 523-538, 2023.

Article in En | MEDLINE | ID: mdl-37737836

Subject(s)

Anti-Bacterial Agents; beta-Lactamase Inhibitors; Humans; beta-Lactamase Inhibitors/pharmacology; Anti-Bacterial Agents/pharmacology; Patents as Topic; beta-Lactamases; Bacteria; Carbapenems; Zinc; Microbial Sensitivity Tests

Key words

Class B; MBLs; antibiotic resistance; carbapenems; inhibitors; metallo-ß-lactamases; patents

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Beta-Lactamase Inhibitors / Anti-Bacterial Agents Limits: Humans Language: En Journal: Expert Opin Ther Pat Journal subject: TERAPEUTICA Year: 2023 Document type: Article Affiliation country: France Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google